| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $80.3M | +15.8% |
| Gross Profit | $54.3M | +16.9% |
| R&D Expense | $9.2M | +4.6% |
| SG&A Expense | $15.7M | +6.6% |
| Operating Income | -$33.8M | +1.1% |
| Pre-tax Income | -$38.6M | -1.6% |
| Income Tax | $230K | +259.7% |
| Net Income | -$38.8M | -2.6% |
| EPS (Basic) | -$0.83 | +37.6% |
| EPS (Diluted) | -$0.83 | +37.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $50.8M | -3.5% |
| Accounts Receivable | $10.3M | +2.5% |
| Inventory | $11.0M | -13.8% |
| Current Assets | $75.6M | -3.2% |
| Total Assets | $81.4M | -6.0% |
| Current Liabilities | $18.0M | +15.2% |
| Long-term Debt | $55.7M | +35.3% |
| Total Liabilities |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$28.2M | +32.2% |
| Capital Expenditures | $448K | -54.7% |
| Investing Cash Flow | $846K | -81.0% |
| Financing Cash Flow | $25.8M | -40.2% |
| Free Cash Flow | -$28.7M | +32.7% |
| $75.1M |
| +29.2% |
| Stockholders' Equity | $6.3M | -77.8% |